These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3092845)

  • 21. Intramuscular fatty acid metabolism evaluated with stable isotopic tracers.
    Guo Z; Jensen MD
    J Appl Physiol (1985); 1998 May; 84(5):1674-9. PubMed ID: 9572816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valproic acid-induced pancreatitis in childhood epilepsy: case series and review.
    Sinclair DB; Berg M; Breault R
    J Child Neurol; 2004 Jul; 19(7):498-502. PubMed ID: 15526953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ghrelin levels are reduced in prepubertal epileptic children under treatment with carbamazepine or valproic acid.
    Prodam F; Bellone S; Casara G; De Rienzo F; Grassino EC; Bonsignori I; Demarchi I; Rapa A; Radetti G; Bona G
    Epilepsia; 2010 Feb; 51(2):312-5. PubMed ID: 19780793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gas liquid chromatographic studies of [1-14C] palmitate uptake by the perfused guinea-pig heart.
    Fields M; Gloster J; Harris P
    Res Commun Chem Pathol Pharmacol; 1979 May; 24(2):409-12. PubMed ID: 461996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of valproate on mitochondrial function in epileptic patients].
    Kanayama M; Sugiyama N; Morishita H; Ishikawa T; Wada Y; Akiyama T
    No To Hattatsu; 1985 Nov; 17(6):507-13. PubMed ID: 3936523
    [No Abstract]   [Full Text] [Related]  

  • 26. [Fatty acid metabolism using C-11 palmitate: (1). Resting study].
    Tamaki N; Yonekura Y; Magata Y; Saji H; Fujibayashi Y; Sasayama S; Yamashita K; Ohtani H; Fujita T; Yamada T
    Kaku Igaku; 1990 Apr; 27(4):313-21. PubMed ID: 2376917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin resistance in epileptic girls who gain weight after therapy with valproic acid.
    Verrotti A; Basciani F; De Simone M; Trotta D; Morgese G; Chiarelli F
    J Child Neurol; 2002 Apr; 17(4):265-8. PubMed ID: 12088081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of phenformin and alpha-bromopalmitate on fatty acid and glucose oxidation in muscle.
    Tutwiler GF
    Res Commun Chem Pathol Pharmacol; 1978 Mar; 19(3):541-4. PubMed ID: 653108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of chronic N-dipropylacetamide ("depamide") treatment on plasmatic immunoglobulins of epileptic patients.
    Musolino R; Natoli M; Gallitto G; Morgante L; Serra S; Pisani F; Di Perri R
    Acta Neurol (Napoli); 1980 Apr; 2(2):115-20. PubMed ID: 6771967
    [No Abstract]   [Full Text] [Related]  

  • 30. Precocious puberty in an epileptic child treated with valproate.
    Zaiem A; Aouinti I; Lakhoua G; Kastalli S; Daghfous R; Lakhal M; El Aïdli S
    Therapie; 2012; 67(6):537-8. PubMed ID: 23249581
    [No Abstract]   [Full Text] [Related]  

  • 31. Further observations on the measurement of fatty acid incorporation by erythrocyte ghosts to quantify unbound palmitate concentration in albumin-palmitate mixtures.
    Pond SM; Gordon RA; Simi AL; Winzor DJ
    Anal Biochem; 1996 Jun; 237(2):232-8. PubMed ID: 8660571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Adverse effects of valproic acid in epileptic infants and adolescents].
    Devilat M; Blumel JE
    Rev Chil Pediatr; 1991; 62(6):362-6. PubMed ID: 1845642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatty acid chain shortening in humans.
    Schoeller DA
    Am J Clin Nutr; 1989 Dec; 50(6):1473-4. PubMed ID: 2512807
    [No Abstract]   [Full Text] [Related]  

  • 34. Serum carnitine, beta-hydroxybutyrate and ammonia levels during valproic acid therapy.
    Toksoy HB; Tanzer FN; Atalay A
    Turk J Pediatr; 1995; 37(1):25-9. PubMed ID: 7732605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asymptomatic hyperammonemia in children treated with valproic acid.
    Altunbaşak S; Baytok V; Tasouji M; Hergüner O; Burgut R; Kayrin L
    J Child Neurol; 1997 Oct; 12(7):461-3. PubMed ID: 9373804
    [No Abstract]   [Full Text] [Related]  

  • 36. [Severe oedema after valproate and valpromide].
    Galland MC; Nguyen N; Alla P; Ruiz JM; Rodor F; Valli M
    Therapie; 2002; 57(2):194-6. PubMed ID: 12185971
    [No Abstract]   [Full Text] [Related]  

  • 37. Commentary to: "Evaluation of serum lipids and carotid artery intima media thickness in epileptic children treated with valproic acid".
    Belcastro V; Striano P
    Brain Dev; 2009 Jun; 31(6):474. PubMed ID: 19268510
    [No Abstract]   [Full Text] [Related]  

  • 38. Cognitive side effects of valproic acid-induced hyperammonemia in children with epilepsy.
    Nicolai J; Aldenkamp AP; Huizenga JR; Teune LK; Brouwer OF
    J Clin Psychopharmacol; 2007 Apr; 27(2):221-4. PubMed ID: 17414255
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical and electroencephalographic study of the effects of valpramide in treating epilepsy].
    Zhou SS
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Jun; 18(3):142-4. PubMed ID: 3932024
    [No Abstract]   [Full Text] [Related]  

  • 40. ORIGIN OF PALMITIC ACID CARBON IN PALMITATES FORMED FROM HEXADECANE-1-C-14 AND TETRADECANE-1-C-14 BY MICROCOCCUS CERIFICANS.
    FINNERTY WR; KALLIO RE
    J Bacteriol; 1964 Jun; 87(6):1261-5. PubMed ID: 14188700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.